# Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)

> **NCT03575403** · PHASE1 · COMPLETED · sponsor: **Craig Rush** · enrollment: 19 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Alcohol
- **DRUG:** Placebos
- **DRUG:** Duloxetine (60 MG)
- **DRUG:** Methylphenidate
- **DRUG:** Duloxetine (30 MG)

## Key facts

- **NCT ID:** NCT03575403
- **Lead sponsor:** Craig Rush
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-03-15
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2025-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575403, "Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03575403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*